ConductScience.org, home

Paper32061310

TP53 Mutations and Outcomes in Breast Cancer: Reading beyond the Headlines.

Shahbandi A and 2 others. Trends Cancer, 2020. Cited by 162 papers, by iCite.

Cite this record

ConductScience Library. TP53 Mutations and Outcomes in Breast Cancer: Reading beyond the Headlines. Papers, record 32061310. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32061310

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
TP53 Mutations and Outcomes in Breast Cancer: Reading beyond the Headlines.
PubMed
Journal
Trends Cancer
PubMed
Year
2020
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S., Review
PubMed
Citations, by iCite
162
iCite
Relative citation ratio, by iCite
7.38
iCite
Revised in PubMed
2024-03-31
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Shahbandi AAshkan
2Nguyen HDHoang D
3Jackson JGJames G

Source PubMed

Download CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic Combined Chemotherapy ProtocolsMajor topic
Breast NeoplasmsMajor topic
MastectomyMajor topic
Neoadjuvant TherapyMajor topic
Tumor Suppressor Protein p53Major topic
Animals
Breast
Chemotherapy, Adjuvant
Clinical Decision-Making
DNA Mutational Analysis
Disease Models, Animal
Disease-Free Survival
Female
Humans
Mice
Mutation
Patient Selection
Practice Guidelines as Topic

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
TL1 TR003106NCATS NIH HHSUnited StatesTL1TR003106PubMed and NIH

Source NIH RePORTER

Download CSV of grants

References101

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
19649144Predictive value of topoisomerase IIalpha and other prognostic factors for epirubicin chemotherapy in advanced breast cancer.Br J Cancer1998https://conductscience.org/library/papers/9649144PubMed
221556366Predictive and prognostic impact of TP53 mutations and MDM2 promoter genotype in primary breast cancer patients treated with epirubicin or paclitaxel.PLoS One2011https://conductscience.org/library/papers/21556366PubMed
323849169Ionizing-radiation induced DNA double-strand breaks: a direct and indirect lighting up.Radiother Oncol2013https://conductscience.org/library/papers/23849169PubMed
410719728A prospective trial of midwest breast cancer patients: a p53 gene mutation is the most important predictor of adverse outcome.Int J Cancer2000https://conductscience.org/library/papers/10719728PubMed
52056391p53 expression in human breast cancer related to survival and prognostic factors: an immunohistochemical study.J Pathol1991https://conductscience.org/library/papers/2056391PubMed
67882357Racial disparity in the association of p53 gene alterations with breast cancer survival.Cancer Res1995https://conductscience.org/library/papers/7882357PubMed
720549698p53 status influences response to tamoxifen but not to fulvestrant in breast cancer cell lines.Int J Cancer2011https://conductscience.org/library/papers/20549698PubMed
819806450Overexpression of p53 is correlated with poor outcome in premenopausal women with breast cancer treated with tamoxifen after chemotherapy.Breast Cancer Res Treat2010https://conductscience.org/library/papers/19806450PubMed
920228131Cyclophosphamide dose intensification may circumvent anthracycline resistance of p53 mutant breast cancers.Oncologist2010https://conductscience.org/library/papers/20228131PubMed
1024909504TP53 status predicts long-term survival in locally advanced breast cancer after primary chemotherapy.Acta Oncol2014https://conductscience.org/library/papers/24909504PubMed
1119097774New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).Eur J Cancer2009https://conductscience.org/library/papers/19097774PubMed
1230605222Association Between Reimbursement Incentives and Physician Practice in Oncology: A Systematic Review.JAMA Oncol2019https://conductscience.org/library/papers/30605222PubMed
1311912168DNA damage is able to induce senescence in tumor cells in vitro and in vivo.Cancer Res2002https://conductscience.org/library/papers/11912168PubMed
1412563311The role of p53 in determining sensitivity to radiotherapy.Nat Rev Cancer2003https://conductscience.org/library/papers/12563311PubMed
158259215A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.Nature1993https://conductscience.org/library/papers/8259215PubMed
1628427202Clinical implications of genomic profiles in metastatic breast cancer with a focus on TP53 and PIK3CA, the most frequently mutated genes.Oncotarget2017https://conductscience.org/library/papers/28427202PubMed
1723873310The impact of p53 in predicting clinical outcome of breast cancer patients with visceral metastasis.Sci Rep2013https://conductscience.org/library/papers/23873310PubMed
1811289122Influence of TP53 gene alterations and c-erbB-2 expression on the response to treatment with doxorubicin in locally advanced breast cancer.Cancer Res2001https://conductscience.org/library/papers/11289122PubMed
1916968874Evaluation of the prognostic and predictive value of p53 and Bcl-2 in breast cancer patients participating in a randomized study with dose-dense sequential adjuvant chemotherapy.Ann Oncol2006https://conductscience.org/library/papers/16968874PubMed
2022198468Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657).Breast Cancer Res Treat2012https://conductscience.org/library/papers/22198468PubMed

See all 101 referencesDownload CSV of references

Cited by132

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 162 citations.

PMIDTitleJournalYearIn PapersSource
42853938Targeting SUV39H2 exon skipping reverses resistance to CDK4/6 inhibitors via transcriptional activation of p21.Sci Adv2026https://conductscience.org/library/papers/42853938PubMed
42701099Covalent Targeting and Thermostabilization of Oncogenic R280K and R273H Mutants p53 by Small Molecule RVJB59.ChemMedChem2026https://conductscience.org/library/papers/42701099PubMed
42630554Clinical outcomes and genomic landscape of anti-HER2 antibody-drug conjugates in HER2-positive and HER2-low metastatic breast cancer.Ther Adv Med Oncol2026https://conductscience.org/library/papers/42630554PubMed
42467271Succinylation related gene signature enables risk stratification and prognostic modeling in breast cancer patients.Amino Acids2026https://conductscience.org/library/papers/42467271PubMed
42449678Naturally Occurring Feline Cancers in Comparative Oncology: Translational Insights from Oral Squamous Cell Carcinoma and Mammary Carcinoma.Cancers (Basel)2026https://conductscience.org/library/papers/42449678PubMed
42352496Genomic Profiling of Breast Cancer in an Ecuadorian Cohort Reveals Clinically Relevant Variants and Ancestry-Related Interpretation Challenges.Cancers (Basel)2026https://conductscience.org/library/papers/42352496PubMed
42325535
Development of a LiDia-SEQ™ platform compatible breast cancer panel and testing with metastatic breast cancer patient samples: A rapid, sample-to-result, fully integrated next-generation sequencing (NGS)-based platform, LiDia-SEQ, for use at the point-of-need.
J Liq Biopsy2026https://conductscience.org/library/papers/42325535PubMed
42316306
Large-scale transcriptomic data mining using explainable XGBoost and SHAP reveals shared biomarkers and molecular mechanisms between type-2 diabetes and triple-negative breast cancer for drug repurposing.
BioData Min2026https://conductscience.org/library/papers/42316306PubMed
42250175Integrating multi-omics and clinical management in breast cancer: a comprehensive review.Discov Oncol2026https://conductscience.org/library/papers/42250175PubMed
42243652Multi-omics network inference with a Gaussian copula model.BMC Bioinformatics2026https://conductscience.org/library/papers/42243652PubMed
42196471Construction of a Lysine Lactylation- and DNA Damage Repair-Related Gene Signature to Predict the Prognosis and Drug Sensitivity of Breast Cancer Patients.Int J Mol Sci2026https://conductscience.org/library/papers/42196471PubMed
42146898DNA Methylation in Blood Samples from Malignant Mammary Tumors of Companion Dogs: A Pilot Study.Comput Struct Biotechnol J2026https://conductscience.org/library/papers/42146898PubMed
42101677Circadian clock control of breast cancer hallmarks: molecular mechanisms and therapeutic implications.Cancer Metastasis Rev2026https://conductscience.org/library/papers/42101677PubMed
42089753Benchmarking computational methods for multi-omics biomarker discovery in cancer.Brief Bioinform2026https://conductscience.org/library/papers/42089753PubMed
42081559Predicting protein cascade expression from H&E images.PLoS Comput Biol2026https://conductscience.org/library/papers/42081559PubMed
41939469Tamoxifen differentially modulates endometrial hyperplasia via wild-type and mutant p53 regulation of the ALKBH5-REG1A axis.Front Oncol2026https://conductscience.org/library/papers/41939469PubMed
41766646EpGAT: integrating epigenetics and 3D genome structure to predict alternative splicing and polyadenylation.Brief Bioinform2026https://conductscience.org/library/papers/41766646PubMed
41764184Evaluation of non-canonical p53 functions in DNA replication and recombination for variant classification.Cell Death Dis2026https://conductscience.org/library/papers/41764184PubMed
41712721The oncogenome of the domestic cat.Science2026https://conductscience.org/library/papers/41712721PubMed
41646753Predicting Protein Cascade Expression from H&E Images.medRxiv2026https://conductscience.org/library/papers/41646753PubMed

See all 132 cited byDownload CSV of cited by

Genes11

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/32061310

GET https://conductscience.org/api/papers/v1/32061310/references?page=2